About the Product

Description


Acarten 25 M Tablet containing Acarbose and Metformin is used for the management of type 2 diabetes mellitus. It helps control blood sugar levels effectively, especially post-meal glucose spikes.

Acarbose works by slowing carbohydrate absorption in the intestine, while Metformin reduces glucose production in the liver and improves insulin sensitivity.

The tablet is widely prescribed in diabetic care practice for long-term blood sugar management, leading to consistent prescription demand.

With increasing prevalence of diabetes and lifestyle-related metabolic disorders, this product offers strong business potential for retailers and distributors. Its dual mechanism of action, strong clinical acceptance, and steady market demand make it a reliable product for growth in the antidiabetic segment.

Some patients may experience abdominal bloating, flatulence, diarrhea, nausea, or metallic taste. Rarely, lactic acidosis (with Metformin), hypoglycemia (when combined with other antidiabetics), or liver enzyme changes may occur.

Acarten 25 M Tablet is indicated for type 2 diabetes mellitus, especially in patients with postprandial (after meal) blood sugar spikes. It helps lower blood glucose levels, improve insulin response, and support long-term glycemic control.

This medicine should be used under medical supervision. Regular monitoring of blood sugar and kidney function is recommended. It should be taken with meals for best effectiveness.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Acarten 25 M Tablet in the PCD pharma franchise market?

Acarten 25 M Tablet, containing Acarbose 25mg and Metformin 500mg, has strong demand in the anti-diabetic segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on diabetes management portfolios.

Why should medical distributors include Acarten 25 M Tablet in their product range?

Medical distributors and agencies can benefit from the growing demand for combination anti-diabetic therapies used in the management of Type 2 Diabetes Mellitus. The combination of Acarbose and Metformin helps support post-meal glucose control and overall blood sugar management, strengthening a comprehensive diabetic care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Acarten 25 M Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Acarten 25 M Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Acarten 25 M Tablet distribution?

Wholesalers and medical agencies benefit from steady diabetic prescription demand, long-term therapy usage, reliable supply chain support, and good margins when partnering for Acarten 25 M Tablet distribution.

How can I become a distributor or franchise partner for Acarten 25 M Tablet?

Medical distributors, stockists, and wholesalers interested in Acarten 25 M Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.